Evaluating safety and efficacy of zinc ang magnesium supplements in Type 2 diabetic patients along with standard care of treatament

Treatment modalities of antidiabetic agents and role of Zinc and Magnesium supplementation in young type 2 diabetic patients - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071237

Enrollment

Registered

2024-07-25

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Zinc along with standard treatment: Elemental zinc 50 mg once daily for 6 months along with standard drug which are given for duration of 6 months Intervention2: Magnesium along with st

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with Type 2 Diabetes Mellitus. Patients willing to informed consent.

Exclusion criteria

Exclusion criteria: Type 1 diabetic patient and patient on Insulin Pregnancy, diabetic ketoacidosis A cardiovascular event in the 3 months before enrolment Moderate or severe impairment of renal function

Design outcomes

Primary

Measure	Time frame
Mean change in HbA1c from baseline.Timepoint: eighteen months	—

Secondary

Measure	Time frame
-The change from baseline to week 24 in fasting plasma glucose (FPG) -The change from baseline to week 24 in postprandial blood sugar (PPBS) -The change from baseline to week 24 in Body mass Index / weight/waist circumference. -The change from baseline to week 24 in Lipid profile. -The change from baseline to week 24 in Renal function test. -Mean changes from baseline in systolic (SBP) and diastolic blood pressure (DBP) at week 24. Timepoint: eighteen months	—

Measure

Time frame

-The change from baseline to week 24 in fasting plasma glucose (FPG) -The change from baseline to week 24 in postprandial blood sugar (PPBS) -The change from baseline to week 24 in Body mass Index / weight/waist circumference. -The change from baseline to week 24 in Lipid profile. -The change from baseline to week 24 in Renal function test. -Mean changes from baseline in systolic (SBP) and diastolic blood pressure (DBP) at week 24. Timepoint: eighteen months

—

Countries

India

Contacts

Public ContactDR FARHAN AHMAD KHAN

Jawaharlal Nehru Medical college ,AMU

dr.farhan.k@gmail.com9759468300

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026